Documentos de Académico
Documentos de Profesional
Documentos de Cultura
SGB Curico 2005
SGB Curico 2005
(Grupo B)
Embarazo y Sepsis Neonatal
Dr. Fernando Abarza C.
Departamento Obstetricia y Ginecologa
Facultad de Medicina P. Universidad Catlica de Chile
Strepto G-B
E. Coli
Listeria m.
Klebsiella
Otros Strepto
Pseudomona
Perodo 87-89
50%
40%
10%
0
0
0
Perodo 95-96
54%
0%
10%
10%
21%
1%
Streptococcus grupo B
Impacto de la aplicacin de
protocolo de prevencin en sepsis
neonatal precoz por SGB
Si no se hizo cultivo:
MR > 18 hrs Fiebre
MMWR 1996. 45 ( RR-7 ): 16-17
2,5
Group B Strep
Associaton
formed
1st ACOG
& AAP
statements
CDC draft
Guidelines
Published Consansus
guidelines
Early-onset
late-onset
1,5
1
0,5
0
00
20
98
99
19
19
96
97
19
19
94
95
19
19
92
91
90
93
19
19
19
19
19
89
Years
ACOG , American College of Obstetricians and Gynecologists: AAP, American Academy of Pediatrics. Source:
Adapted from CDC. Early-onset group B streptococcal disease. United States, 1998-1999. MMWR 2000;49:7936; and Schrag Sj, Zywicki S. Farley MM. et al. Group B streptococcal disease in the era of intrapartum
antibiotic Prophylaxis. N Engl J Med 2000;342:15-20
Si no se hizo cultivo:
MR > 18 hrs Fiebre
MMWR 1996. 45 ( RR-7 ): 16-17
Por F. de riesgo
Tratamiento:
12-20%
Tratamiento:
10-15%
Prevencin:
> 86%
Prevencin:
70%
x / 1.000
Screening universal
N
x / 1000
Reduccin
Sweet
Main
Hafner
3 / 31.133
1.16
4 / 28.733
0.14
88%
Obstet Gynecol 2000; 95 (4): 496-501
15 / 13.270
1.11
0 / 9.304
0.0
100%
Am J Obstet Gynecol 2000; 182 (6): 1344-54
20 / 3.623
5.5
4 / 3621
1.1
80%
Am J Obstet gynecol 1998. 179 ( 3 ) : 677-681
x / 1.000
1.84
x / 1000
0.73
Reduccin
61%
10
11
12
(20.53%)
(12.70%)
p < 0.05
13
Alternative
If Penicillin allergyallergic
Parient not at high
Clindamycin, 900 mg IV
to clindamycin
and erythromycin
OR
Erythromycin, 500 mg IV every 6 hours until delivery
GBS resistant to
clindamycin or
erythromycin or
susceptibility unknown
183
183
183
177 (96.7%)
176 (96.3%)
2
1
4
6
14
OIA +
OIA -
Cultivo + Cultivo
5
4
13
78
S 27,7%
VPP 55,5%
VPN 85,7%
E 85,7%
Rev Chil Obstet Ginecol 2002; 67 (4): 293-6
Optic Immunoassay
X / 1.000 RNV
50%
40%
54%
0%
17%
28%
15
16
1997 - 1998
eritromicina
clindamicina
ampi / penicilina / cefalo 1
Am J Obstet Gynecol 1999; 181 (2): 310-4
17
18